• News

"FDA Approves First Treatment For Kids With Peanut Allergy" - Lauren Neergaard

  • Associated Press
  • New York, NY
  • (January 31, 2020)

The first treatment for peanut allergies is about to hit the market, a big step toward better care for all kinds of food allergies -- but still a long way from a cure. Named Palforzia, it was developed by Aimmune Therapeutics.” Palforzia users still must carry their rescue medicine, such as EpiPens, to treat severe allergic reactions. “Most experience at least mild side effects, such as hives or stomachaches, and about a fifth dropped out of the study,” said Scott Sicherer, MD, director of the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai. He added, “There is a trade-off, families and doctors together will have to decide does it make sense for me or my child?”

Scott Sicherer, MD, Director, Elliot and Roslyn Jaffe Food Allergy Institute, The Mount Sinai Hospital, Chief, Division of Allergy and Immunology, Professor, Pediatrics, Allergy and Immunology,  Icahn School of Medicine at Mount Sinai

Learn more 

Additional coverage: The New York Times;ABC News Online;Business Insider;U.S. News & World Report; PBS Online; Chicago Tribune; Seattle Times; The Philadelphia Inquirer; Newsday; NBC New York